Astellas Pharma Europe, a European subsidiary of Astellas, has introduced Dificlir (generic name: fidaxomicin) tablets in the Europe. Dificlir, indicated to treat Clostridium difficile infections (CDI), is an orally administered, ...
Tags: Dificlir, fidaxomicin, CDI